Fomepizole saves lives in Coldrif cough syrup poisoning case
- October 7, 2025
- 0
A drug commonly used to counter alcohol poisoning has unexpectedly become a lifesaver in one of India’s most tragic medical incidents. Fomepizole, a medication typically administered to treat methanol or hooch poisoning, has shown remarkable effectiveness against diethylene glycol (DEG) toxicity linked to the contaminated cough syrup Coldrif. The antidote played a crucial role in saving several children in Madhya Pradesh who suffered severe kidney and neurological damage after consuming the tainted medicine.
The Coldrif incident shocked families and health authorities alike when reports emerged of children falling critically ill after taking the syrup. Laboratory tests later revealed that the product contained diethylene glycol, a toxic chemical often used in industrial applications but lethal when ingested. The contamination led to acute kidney failure and brain injury among young patients, prompting an urgent search for an effective treatment.
Medical teams turned to Fomepizole, a drug long recognized for its ability to block the metabolism of toxic alcohols such as methanol and ethylene glycol. In this case, doctors found that it also inhibited the harmful breakdown of diethylene glycol within the body. By preventing further conversion into toxic metabolites, Fomepizole allowed patients’ kidneys and nervous systems to recover more effectively. Its timely administration is believed to have prevented additional fatalities during the crisis.
Diethylene glycol is a colorless, sweet-tasting chemical used primarily as an industrial solvent and antifreeze component. When mistakenly or illegally substituted for pharmaceutical-grade ingredients like glycerin or propylene glycol, it can cause catastrophic health effects. Even small amounts can lead to multi-organ failure, particularly affecting the kidneys and central nervous system. Past global incidents involving DEG-contaminated medicines have underscored the importance of strict quality control in pharmaceutical manufacturing.
In Madhya Pradesh, healthcare professionals acted swiftly once DEG poisoning was confirmed as the cause of illness among affected children. Hospitals coordinated with toxicology experts to administer Fomepizole under controlled supervision. Supportive treatments such as dialysis and hydration therapy were also provided to manage kidney damage and stabilize patients’ conditions. The combination of early diagnosis and targeted antidote therapy proved decisive in improving survival rates.
The Coldrif tragedy has reignited discussions about drug safety standards and regulatory oversight within the pharmaceutical supply chain. Experts emphasize that contamination with industrial chemicals like DEG often results from lapses in ingredient sourcing or inadequate testing procedures. Strengthening manufacturing protocols and enforcing rigorous quality checks are essential steps toward preventing similar disasters in the future.
The successful use of Fomepizole in this case highlights how existing medical knowledge can be repurposed during emergencies to save lives. While the incident exposed serious flaws in drug safety practices, it also demonstrated the resilience and adaptability of India’s healthcare system when faced with unexpected challenges.